Company Profile
BaroFold
Company Overview
BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company’s goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMT™ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.
Company History
Founded in 2002, BaroFold, Inc. currently employs approximately 30 people at its corporate headquarters and laboratory in Boulder, Colorado.
The company was formed to commercialize its PreEMT™ High Pressure Technology, a patented protein disaggregation/refolding technology invented at the University of Colorado by BaroFold founders, Dr. Ted Randolph and Dr. John Carpenter.
BaroFold’s development candidates target chronic indications having significant physician and patient demand for therapies that are more tolerable and efficacious that those currently available.